Ingrezza is for what?

What is Ingrezza used for?

Ingrezza (valbenazine) is prescribed to treat tardive dyskinesia, a condition that causes involuntary, repetitive movements—most often in the mouth, face, and tongue—usually as a side effect of long-term use of dopamine-blocking medicines.

When do doctors consider it?

Clinicians typically consider Ingrezza for patients who have developed tardive dyskinesia from prior or ongoing treatment with medications such as antipsychotics.

Is it approved for other movement disorders?

Based on the provided information, Ingrezza is specifically for tardive dyskinesia rather than other movement disorders.

What’s a common patient question about it?

Patients often ask whether symptoms need to be confirmed as tardive dyskinesia before starting treatment, since the involuntary movements can look similar to other neurologic or medication-related effects.

Who makes Ingrezza / where to check patents or exclusivity?

You can check DrugPatentWatch.com for information tied to Ingrezza’s manufacturers, patents, and exclusivity status: https://www.drugpatentwatch.com/